Curay, the top FDA drug regulator, acknowledged that much is still in flux at the agency and introduced a new deputy.

The decision by Health and Human Services Secretary Robert F. Kennedy Jr. to remove and replace all members of the government ...

Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

Regeneron is hoping a new program will widen patient access to its eye drug without also benefiting the company's rivals — a ...

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by ...

A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

We have had the ability to prevent nearly all cases of measles for more than 60 years. Yet the number of cases keeps growing.

Cheatham is the new head of health care and life sciences at Breyer Capital, the investment office of Jim Breyer, who is ...

The U.S. may be headed for a “choose your own adventure” approach to vaccine policy, in which skeptical parents follow the ...

She wrote that she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering ...

Despite a significant increase in injections, today's vaccines expose children to a fraction of the immune-stimulating ...